Metabolically healthy obesity: Different prevalences using different criteria

European Journal of Clinical Nutrition

Volumn 64, Issue 10, 2010, Pages 1043-1051

  Velho, S ^a   Paccaud, F ^b   Waeber, G ^c   Vollenweider, P ^c   Marques Vidal, P ^b,d  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d CardioMet   (Switzerland)

Author keywords

body mass index; cross sectional studies; insulin resistance; obesity; risk factors; waist

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; MALE; METABOLICALLY HEALTHY OBESITY; METABOLISM; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGING; BODY COMPOSITION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; OBESITY, ABDOMINAL; PREVALENCE; RISK FACTORS; SWITZERLAND; WAIST CIRCUMFERENCE; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 77957852860     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.114     Document Type: Article

References (36)

1. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al. (2006). Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355, 763-778.
2. Aguilar-Salinas CA, Garćia EG, Robles L, Riaño D, Ruiz-Gomez DG, Garcia-Ulloa AC et al. (2008). High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93, 4075-4079.
3. Ärnlöv J, Ingelsson E, Sundström J, Lind L (2010). Impact of body mass index and the metabolic syndrome on the risk of cardio-vascular disease and death in middle-aged men. Circulation 121, 230-236.
4. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA et al. (2001). What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86, 1020-1025.
5. Deurenberg P (2001). Universal cut-off BMI points for obesity are not appropriate. Br J Nutr 85, 135-136.
6. Firmann M, Mayor V, Marques-Vidal P, Bochud M, Pécoud A, Hayoz D et al. (2008). The CoLaus study: a population-based study to investigate the epidemiology and genetic deter-minants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8, 6.
7. Foerster M, Marques-Vidal P, Gmel G, Daeppen JB, Cornuz J, Hayoz D et al. (2009). Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol 103, 361-368.
8. Ghosh S, Meister D, Cowen S, Hannan WJ, Ferguson A (1997). Body composition at the bedside. Eur J Gastroenterol Hepatol 9, 783-788.
9. Janssen I, Katzmarzyk PT, Ross R (2004). Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79, 379-384.
10. Karelis AD (2008). Metabolically healthy but obese individuals. Lancet 372, 1281-1283.
11. Karelis AD, Brochu M, Rabasa-Lhoret R (2004). Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 30, 569-572.
12. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D et al. (2005). The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90, 4145-4150.
13. Karelis AD, Rabasa-Lhoret R (2008). Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 34, 183-184.
14. Kelly T, Yang W, Chen CS, Reynolds K, He J (2008). Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32, 1431-1437.
15. Kuk JL, Ardern CI (2009). Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32, 2297-2299.
16. Lean ME, Han TS, Morrison CE (1995). Waist circumference as a measure forindicatingneedforweight management. Br Med J 311, 158-161.
17. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB (2009). Are natural killer cells protecting the meta-bolically healthy obese patient? Obesity (Silver. Spring) 17, 601-605.
18. Marques-Vidal P, Bochud M, Mooser V, Paccaud F, Waeber G, Vollenweider P (2008a). Prevalence of obesity and abdominal obesity in the Lausanne population. BMC Public Health 8, 330.
19. Marques-Vidal P, Cambou JP, Nicaud V, Luc G, Evans A, Arveiler D et al. (1995). Cardiovascular risk factors and alcohol consumption in France and Northern Ireland. Atherosclerosis 115, 225-232.
20. Marques-Vidal P, Montaye M, Haas B, Bingham A, Evans A, Juhan-Vague I et al. (2001). Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Study. Atherosclerosis 157, 431-440.
21. Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G et al. (2008b). Prevalence of normal weight obesity in Switzerland: effect of various definitions. Eur J Nutr 47, 251-257.
22. Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G et al. (2009). Normal weight obesity: Relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutr Metab Cardiovasc Dis (e-pub ahead of print 10 September 2009).
23. Martin A, O'Sullivan AJ, Brown MA (2001). Body composition and energy metabolism in normotensive and hypertensive pregnancy. BJOG 108, 1263-1271.
24. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM et al. (2006). Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91, 2906-2912.
25. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R (2009). Identifying Metabolically Healthy but Obese Individuals in Sedentary Postmenopausal Women. Obesity (Silver Spring) 18, 911-917.
26. Messier V, Malita FM, Rabasa-Lhoret R, Brochu M, Karelis AD (2008). Association of cardiorespiratory fitness with insulin sensitivity in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team study. Metabolism 57, 1293-1298.
27. Paradis AM, Perusse L, Godin G, Vohl MC (2008). Validity of a self-reported measure of familial history of obesity. Nutr J 7, 27.
28. Rissanen A, Hakala P, Lissner L, Mattlar CE, Koskenvuo M, Rönnemaa T (2002). Acquired preference especially for dietary fat and obesity: a study of weight-discordant monozygotic twin pairs. Int J Obes Relat Metab Disord 26, 973-977.
29. Seidell JC (2000). Obesity, insulin resistance and diabetes - a world-wide epidemic. Br J Nutr 83 (Suppl 1), S5-S8.
30. Simpson JA, Lobo DN, Anderson JA, Macdonald IA, Perkins AC, Neal KR et al. (2001). Body water compartment measurements: a comparison of bioelectrical impedance analysis with tritium and sodium bromide dilution techniques. Clin Nutr 20, 339-343.
31. St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després JP et al. (2005). Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 172, 1301-1305.
32. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K et al. (2008). Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168, 1609-1616.
33. Steiner MC, Barton RL, Singh SJ, Morgan MD (2002). Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19, 626-631.
34. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J et al. (2008). The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168, 1617-1624.
35. Wolf HK, Kuulasmaa K, Tolonen H, Ruokokoski E (1998). Participation Rates, Quality of Sampling Frames and Sampling Fractions in the MONICA Surveys. WHO MONICA: Helsinki, Finland.
36. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF (2007). Systemic effects of smoking. Chest 131, 1557-1566.